1. Debré R, Semölaigne G. Syndrome of diffuse hypertrophy in infants causing athletic appearance. Its connection with congenital myxodema. Am JDis Child. 1935;50:1351-1361.
2.
2. Goldman J, Metz R, Mortimar R, Freeman R. High elevations of creatinine phosphokinase in hypothyroidism. JAMA. 1977;238:325-326.
3.
3. Klein I, Mantell P, Parker M, et al. Resolution of abnormal muscle enzyme studies in hypothyroidism. Am J Med Sci. 1980;279:159-162.
4.
4. Sterling K. Thyroid hormone action at the cell level. N Engl J Med. 1979; 300:117-123, 173-177.
5.
5. Oppenheimer JH. Thyroid hormone action at the nuclear level. Ann Intern Med. 1985;102:374-384.
6.
6. Narusawa M, Fitzsimmons RB, Izumo S, et al. Slow myosin in developing rat skeletal muscle. J Cell Bio L. 1987;104: 447-459.
7.
7. McKeran RO, Slavin G, Ward P, et al. Hypothyroid myopathy. A clinical and pathological study. J Pathol. 1980; 132:35-54.
8.
8. Kjeldsen K, Norgaard A, Gotzsche CO, et al. Effect of thyroid function on number of Na-K pumps in human skeletal muscle. Lancet. 1984;1:8-12.
9.
9. Nickel SN, Frame B, Bekim J, et al. Myxodema neuropathy and myopathy. A clinical and pathologic study. Neurology. 1961;11:125-137.
10.
10. Khaleeli AA, Gohil K, McPhail G, et al. Muscle morphology and metabolism in hypothyroid myopathy: effects of treatment. J Clin Pathol. 1983;36: 519-526.
11.
11. Mastaglia FL, Ojeda VJ, Sarnat HB, Kakulas BAMyopathies associated with hypothyroidism: a review based upon 13 cases. Aust NZJMed. 1988;18: 799-805.
12.
12. Doran GRSerum enzyme disturbances in thyrotoxicosis and myxodema.JR Soc Med. 1978;71:189-194.
13.
13. Sarnat HBNew insight into the pathogenesis of congenital myopathies. J Child Neurol. 1994;9:193-193.
